Ninepoint Partners’s Patterson-UTI PTEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PTEN
SG
Ninepoint Partners's PTEN Position: Q1 2026 in Review
Ninepoint Partners sold out of Patterson-UTI (PTEN) in Q1 2026, closing a stake of 500,000 shares — an estimated $3.06M sold.
Ninepoint Partners first reported a position in PTEN in Q3 2017 and held it in 5 quarters. The position peaked at $51.8M in Q2 2024. 414 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.
- Ninepoint Partners reported no remaining Patterson-UTI position as of Q1 2026 after selling out during the quarter.
- Ninepoint Partners sold 500,000 Patterson-UTI shares in Q1 2026, an estimated $3.06M.
- Ninepoint Partners first reported a position in Patterson-UTI in Q3 2017 and held it in 5 quarters.
- Ninepoint Partners's Patterson-UTI position peaked at $51.8M in Q2 2024.
- 414 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.
Based on Ninepoint Partners's 13F filing for Q1 2026, filed 11 Aug 2026.